https://www.truescoopnews.com/bharat-biotech

Find whatever's trending in Punjab, India and the world on True Scoop News. From Breaking news to analysis of the trending topics, True Scoop covers it all

bharat-biotech

Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.

Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech

Hyderabad-based pharma major Bharat Biotech's US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US FDA for Covaxin to be administered in children aged two to 18 years.

Bharat Biotech's US partner Ocugen seeks Covaxin approval for kids

The Drug Controller General of India will issue final approval after which Covaxin will be the only vaccine approved for use on children.

Bharat Biotech’s Covaxin for children aged 2-18 gets emergency approval from expert panel

Bharat Biotech's Covaxin will get approval from the World Health Organisation (WHO) this week.

WHO approval for Bharat Biotech’s Covaxin likely this week: Report

Reportedly, disruption at Bharat Biotech’s plant assumed significance because a slowdown in the vaccination was witnessed.

Covaxin batches rejected in July due to ‘Stability Issues’ in Bharat Biotech's Bengaluru Plant

Covaxin supplies were disrupted as the initial batches from Bharat Biotech faced some stability issues and hence were rejected.

Covaxin supplies disrupted in July due to ‘issues’ in Bengaluru plant

Underlining four major causes of trouble to the states, the ministry also gave detailed advisories to the states and UTs.

Centre Expresses 'Cause For Serious Worry' on Private Vaccination Centre's Slow Pace

Bharat Biotech has begun the trials this month and vaccine efficacy against coronavirus infection in children as young as two is being tested.

News